Ondansetron Tablet, Orally Disintegrating
Product Images NDC 55154-3680

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-3680). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron HCl Structural Formula (Image 01)

Ondansetron 4 mg orally disintegrating tablets, USP, in a 10-tablet blister pack. The label states each tablet contains 4 mg ondansetron and includes warnings, storage instructions, and manufacturer details. Manufactured by Glenmark Pharmaceuticals Ltd. and packaged for Cardinal Health.*

FDA Label Image

Logo

FDA Label Image

Structure Base

Chemical structure of Ondansetron, showing its molecular composition with a fused bicyclic ring system, a ketone group, and a methylated imidazole moiety.*

FDA Label Image

Structure HCl

Chemical structure diagram of Ondansetron hydrochloride dihydrate, showing the molecule's arrangement of rings and bonds including an indole moiety and a methyl-substituted imidazole ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.